| HS739066 |
Anti-Human TIGIT Reference Antibody (Tamgiblimab |
Tamgiblimab (HS739066) is a research-grade recombinant antibody targeting VSTM3. Produced in mammalian cells with native-like glycosylation.
Highlights
●Research Grade — For PK/PD studies, assay development, and ADA research.
●Native Glycosylation — Mammalian expression ensures native-like patterns.
|
VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains |
